The National Cancer Plan for England outlines a long-term vision to transform cancer care, moving away from short-term fixes toward coordinated system-wide improvements. The strategy emphasises better survival rates, earlier diagnosis, personalised care, research advancement, and inequality reduction. This piece is an overview of all five priorities; we look at two of them in more depth in their own articles, linked below.
Global Leader in Cancer Survival
A primary goal targets 75% of cancer patients to be cancer-free or living well five years post-diagnosis by 2035, potentially saving approximately 320,000 additional lives. This represents a shift from incremental improvement towards genuine transformation addressing underlying causes rather than managing systemic pressures. We look at what reaching that figure would actually require, and how far England currently is from it, in understanding England’s 75% survival target.
Faster, Smarter Diagnosis and Treatment
The plan commits to delivering 9.5 million additional diagnostic tests by 2029 with £2.3 billion investment, rolling out national lung cancer screening by 2030, and expanding artificial intelligence and robotics in imaging and pathology. Early diagnosis remains one of the strongest predictors of cancer survival. The diagnostic capacity, screening and technology commitments behind that ambition are covered in strengthening the cancer pathway in England.
Personalised, Patient-Centred Care
Key commitments include individualised cancer care plans for every patient, expanded digital tools through the NHS App for appointment and screening management, and strengthened community-based and neighbourhood support systems. The approach recognises the wider physical, emotional and social impact of a cancer diagnosis.
Research, Trials and Innovation
The strategy aims to strengthen England's research leadership by increasing clinical trial participation, including for underrepresented populations, and drawing on genomics, diagnostics, and data analytics.
Tackling Inequality and Prevention
Priorities address socioeconomic disparities in cancer outcomes through improved diagnostic access in deprived communities and strengthened prevention initiatives targeting smoking, obesity, and other risk factors.
Conclusion
This is the most comprehensive cancer strategy in a generation, requiring sustained delivery over ten years to achieve world-class, effective, humane, and resilient cancer care.
